Author Question: Which assessment finding could indicate hemorrhage in the postpartum patient? a. Firm fundus at ... (Read 100 times)

Alygatorr01285

  • Hero Member
  • *****
  • Posts: 564
Which assessment finding could indicate hemorrhage in the postpartum patient?
 
  a. Firm fundus at the midline
  b. Saturation of two perineal pads in 4 hours
  c. Elevated blood pressure
  d. Elevated pulse rate

Question 2

The nurse is reviewing the laboratory test results of a child who is receiving chemotherapy.
 
  To calculate the child's absolute neutrophil count, in addition to the total number of white blood cells, which results would the nurse use? Select all answers that apply.
  A) Bands
  B) Segs
  C) Eosinophils
  D) Basophils



Chocorrol77

  • Sr. Member
  • ****
  • Posts: 313
Answer to Question 1

D
An increasing pulse rate is an early sign of excessive blood loss.
A firm fundus indicates that the uterus is contracting and compressing the open blood vessels at the placental site.
Saturation of one pad within the first hour is the maximum normal amount of lochial flow. Two pads within 4 hours is within normal limits.
If the blood volume were diminishing, the blood pressure would decrease.

Answer to Question 2

A, B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

Acetaminophen (Tylenol) in overdose can seriously damage the liver. It should never be taken by people who use alcohol heavily; it can result in severe liver damage and even a condition requiring a liver transplant.

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

Did you know?

The Romans did not use numerals to indicate fractions but instead used words to indicate parts of a whole.

Did you know?

Less than one of every three adults with high LDL cholesterol has the condition under control. Only 48.1% with the condition are being treated for it.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library